Clinical Genomics
  • About
    • Why Us
    • Leadership
    • Board
    • Our History
  • Products
    • COLVERA®
    • Insure® ONE™
  • Clinical Publications
  • News
  • Contact

Leadership

Why Us
leadership
board
our history
Picture
Michael Paris
Chief Executive Officer
Michael Paris is an accomplished product development and operations executive with extensive experience in lifecycle management of innovative medical devices. He brings expertise in building and leading technology development and operations in early-stage ventures, as well as mature companies. Additionally, he has led and contributed to the successful regulatory authorizations (PMA and 510(k)) and commercial launch of numerous products. Prior to becoming CEO, Mr. Paris was Clinical Genomics’ Chief Operating Officer with oversight of all business subsidiaries.   Prior to joining Clinical Genomics, he served as Chief Operating Officer and Senior Vice President, Operations and Technology Development, at Origin Inc., a biotechnology company. He had also held positions of increasing responsibility at Bioconnect Systems, a medical device company; Orthovita, Inc., which was acquired by Stryker Corporation in 2011, and Rex Medical, a medical device company specializing in the development, manufacturing, and marketing of innovative, minimally invasive medical devices. Mr. Paris received his BS degree in Mechanical Engineering Technology from Temple University, and an Executive MBA from Lebow College of Business, Drexel University.

Picture
Lawrence LaPointe, PhD
Scientific Advisor and Co-Founder
Larry LaPointe, PhD, has more than two decades building healthcare companies to transform cancer testing, including most recently as co-founder of Clinical Genomics. He previously served as CTO and general manager of Enterix Inc, a cancer screening company he also co-founded. Dr. LaPointe is a well-published research scientist and holds numerous patents in biomarker discovery, cancer detection and molecular diagnostics. He has a BS in Biology from Florida State University and a PhD in Bioinformatics from Flinders University, Australia.

Picture

Susanne K. Pedersen, PhD
​
Scientific Advisor and Co-Founder
Susanne Pedersen has deep commercial experience focused on biomarker discovery and validation including product concept to successful commercial launch. IVD assay expertise includes molecular diagnostics, proteomics, and immunoassays in esoteric pathology labs as well as point of care testing. Since 2010, her concentrated expertise has been in epigenetics and cell free DNA measurements for cancer detection. Dr. Pedersen is the Inventor of biomarker discovery patents and has a successful track record building cross-functional teams that meet commercial milestones including scale up. B.Sc. (Cell Biology; Southern University of Denmark, 1996); Ph.D. (Molecular Biology; Southern University of Denmark; 2000).
Company
Why Us
Leadership
News & Insights
Support
Contact
​Disclaimers
HIPAA/Privacy
Licenses

Terms of Use
ETXUS-1094[1]
Copyright © 2022 Clinical Genomics Technologies Pty Ltd. All Rights Reserved.
  • About
    • Why Us
    • Leadership
    • Board
    • Our History
  • Products
    • COLVERA®
    • Insure® ONE™
  • Clinical Publications
  • News
  • Contact